| 1 |
Bertinojr. Cancer research: from folate antagonism to molecular targets [J]. Best Pract Res Clin Haematol, 2009, 22(4): 577-582.
|
| 2 |
刘晓明，栾莉. 银屑病的长期治疗和管理 [J]. 中国皮肤性病学杂志, 2013, 27(1): 1-4.
|
| 3 |
肖志坚. 急性白血病化疗药物所致肝损害的诊治 [J]. 中国实用内科杂志, 2011, 31(12) : 910-911.
|
| 4 |
Gurcharan A, Prashant B, Jagdeep S. Methotrexate-induced liver cirrhosis in a patient of psoriasis [J]. JAPJ, 2012, 60(5): 47-48.
|
| 5 |
Berge G, Lundquist A, Rorsman H, et al. Liver biopsy in psoriasis [J]. Br J Dermatol, 1970, 82: 250-253.
|
| 6 |
Malatjalian DA, Ross JB, Williams CN, et al.Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia,with analysis of risks from obesity,diabetes and alcohol consumption during long term follow-up [J]. Can J Gastroenterol, 1996, 10: 369-375.
|
| 7 |
邓雪蓉，张卓莉. 银屑病和银屑病关节炎研究评价组发布2015银屑病关节炎治疗建议[J]. 中华风湿病学杂志, 2016, 20(9): 646-648.
|
| 8 |
Tilling L, Townsend S, David J. Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis [J]. Clin Drug Investig, 2006, 26: 55-62.
|
| 9 |
Roenigk HH Jr, Auerbach R, Maibach HI, et al. Methotrexate in psoriasis: consensus conference [J]. J Am Acad Dermatol, 1998, 38: 478-485.
|
| 10 |
Zachariae H, Heickendorff L,Sogaard H. The value of aminoterminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up [J]. Br J Dermatol, 2001, 144: 100-3.
|